Barry Singer, MD - Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston?

Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston?

Source: PeerView CME/CE Audio Podcast - Immunology - July 10, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts